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Abstract
Background: Antimicrobial stewardship programs (ASPs) are important tools to foster
prudent antimicrobial use.
Objective: To evaluate antimicrobial prescriptions by Swiss veterinarians before and
after introduction of the online ASP AntibioticScout.ch in December 2016.
Animals: Dogs presented to 2 university hospitals and 14 private practices in 2016 or
2018 for acute diarrhea (AD; n = 779), urinary tract infection (UTI; n = 505), respira-
tory tract infection (RTI; n = 580), or wound infection (WI; n = 341).
Methods: Retrospective study. Prescriptions of antimicrobials in 2016 and 2018
were compared and their appropriateness assessed by a justification score.
Results: The proportion of dogs prescribed antimicrobials decreased significantly
between 2016 and 2018 (74% vs 59%; P < .001). The proportion of prescriptions in
complete agreement with guidelines increased significantly (48% vs 60%; P < .001)
and those in complete disagreement significantly decreased (38% vs 24%; P < .001)
during this time. Antimicrobial prescriptions for dogs with AD were significantly cor-
related with the presence of hemorrhagic diarrhea in both years, but a significantly
lower proportion of dogs with hemorrhagic diarrhea were unnecessarily prescribed
antimicrobials in 2018 (65% vs 36%; P < .001). In private practices, in 2018 a bacterial
etiology of UTI was confirmed in 16% of dogs. Prescriptions for fluoroquinolones sig-
nificantly decreased (29% vs 14%; P = .002). Prescriptions for antimicrobials
decreased significantly in private practices for RTI (54% vs 31%; P < .001).
Abbreviations: AD, acute diarrhea; ASP, antimicrobial stewardship program; BAL, bronchoalveolar lavage; HPCIA, highest priority critically important antimicrobial; ISCAID, international society
for companion animal infectious diseases; JS, justification score; RTI, respiratory tract infection; UTI, urinary tract infection; WI, wound infection.
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Conclusion: Antimicrobials were used more prudently for the examined indications in
2018 compared to 2016. The study highlights the continued need for ASPs in veteri-
nary medicine.
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1 | INTRODUCTION
Antimicrobial stewardship refers to interventions designed to foster the
prudent use of antimicrobial agents with the aim of optimizing clinical
outcomes while minimizing unintended consequences of antimicrobial
use, such as adverse effects and the emergence of resistance.1 Antimi-
crobial stewardship programs (ASPs) are often multifaceted and include
guidelines, surveillance, education, preauthorization, and audit of prac-
tice.2 In human medicine, individual or bundled ASP measures are
effective in reducing antimicrobial prescriptions without increase in
mortality.3-9 Antimicrobial stewardship provided via national and local
guidelines positively influences antimicrobial prescribing habits in
human and veterinary medicine leading to both a decreased and more
appropriate use as well as a reduction in resistance.3-13
In 2015, the Swiss National Strategy on Antibiotic Resistance (StAR)
was passed by the federal council. As part of its implementation, an online
tool (AntibioticScout.ch) assisting veterinarians in the selection of prudent
empirical antimicrobial treatment based on international guidelines was
created.14,15 The tool allows users to retrieve short and specific recom-
mendations for antimicrobial treatment online after selection of species,
organ system, and suspected or confirmed diagnosis. The result of a sea-
rch may also recommend to refrain from antimicrobial treatment in the
absence of specific indications. This tool became available to veterinarians
in December 2016 as an extension of a well-established and highly
frequented drug information web site (CliniPharm.ch). AntibioticScout.ch
was promoted to Swiss veterinarians in various ways, including
publications,14,15 newsletters of the Swiss Veterinary Society, flyers, and
continuing education events for practitioners. The prescribing habits of
veterinarians for selected diseases in cats and dogs in Switzerland before
introduction of AntibioticScout.ch have been reported.16,17
The aim of this study was to evaluate whether there is a change in
antimicrobial prescriptions by Swiss veterinarians after the introduction
of the online ASP tool AntibioticScout.ch. Four conditions in dogs that
are often inappropriately treated with antimicrobials, including acute
diarrhea (AD), urinary tract infection (UTI), respiratory tract infection
(RTI), and wound infections (WI) were assessed.
2 | MATERIALS AND METHODS
2.1 | Study design
This retrospective multi-center study is based on clinical and antimi-
crobial prescription data from 2 university hospitals with caseloads of
6000 and 12 000 cases/year and 14 private practices across Switzer-
land ranging from 1-vet mixed practices to middle-sized small animal
clinics. It also included 1 large private clinic with over 80 000 cases
per year. The clinics and practices enrolled in the study on a voluntary
basis after being introduced to the online tool AntibioiticScout.ch. The
exact number of veterinarians prescribing antimicrobials in these
clinics and practices as well as their individual awareness and use of
AntibioticScout.ch were not examined. However, at the time of the
study, the web site was accessed 300 to 600 times per day. Data from
2016, before introduction of AntibioticScout.ch, were compared to
data from 2018.
2.2 | Data collection
Suitable dogs were identified by full text searches of electronic medi-
cal records by predefined search terms (Table 1). Inclusion criteria for
dogs with AD, proven or suspected UTI, proven or suspected RTI, or
WI are shown in Table 1.
Private practices by the OblonData (Amacker & Partner
Informatik AG, Switzerland) or Diana SUISSE (Diana Software AG,
Switzerland) practice management software were enrolled on a volun-
tary basis. For private practices, the necessary sample size was calcu-
lated to estimate the prevalence of antimicrobial treatment according
to guidelines with a precision of ±8%, assuming a prevalence of 50%,
a confidence level of 95% and a population size of 550.000 registered
dogs in Switzerland.18 The sample size of 151 cases per indication and
year, which was determined with the Epitools online calculator
(https://epitools.ausvet.io/site/samplesize), was rounded up to a tar-
get sample size of 160. To avoid overrepresention of large practices,
the number of cases per practice was limited to 16 (10% of the target
sample size), which were randomly selected via the sampling function
in EXCEL. As the number of participating practices exceeded the
expected number of 10, the number of samples per indication and
year for private practices exceeded the target sample size of 160. For
university clinics, all available cases were included, in order to get
close to the target sample size of 160 cases per indication.
As dogs with uncomplicated abscesses and bite wounds are rarely
presented to university hospitals, these cases were only assessed in
private practices.
Antimicrobial prescription data (class, dosage, frequency of appli-
cation, duration of treatment) were recorded for each case together
with signalment, vaccination status, clinical history, physical examina-
tion findings, diagnostic work-up and comorbidities (acute or chronic
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diseases present at the same time as the primary complaint). If antimi-
crobials could unequivocally be assigned to the treatment of coinfec-
tion of a different organ system, they were not taken into account.
2.3 | Definitions
Sepsis was defined as the presence of lethargy plus at least 1 of the
following: body temperature >39.4C, heart rate >140/min, WBC <4
or >25 × 109/L, banded neutrophils >1.5 × 109/L.19 Bacteriuria was
defined as the presence of bacteria in microscopic sediment analysis
or bacterial culture of a urine sample, which was collected aseptically
by cystocentesis.
In accordance with previous guidelines, UTIs were classified as
complicated in cases of infection in the presence of anatomical or
functional changes or disorders of the immune system, recurrent
UTI (three or more times per year) and UTI in noncastrated male
dogs.20 In the meantime, UTI have been reclassified as either spo-
radic, recurrent, or persistent,21 and recommendations on
AntibioticScout.ch have been revised accordingly in 2019. The cor-
rect treatment according to culture and sensitivity profile was
defined as follows: (a) Susceptibility of the cultured bacteria to cho-
sen antimicrobial, (b) sufficient antimicrobial penetration into site of
infection, and (c) preference given to those that are not considered
highest priority critically important antimicrobials (HPCIAs) when-
ever possible.
As suggested by the World Health Organization, third or fourth
generation cephalosporins, fluoroquinolones, macrolides, ketolides,
glycopeptides, and polymyxins were considered HPCIAs.22 Treatment
with 2 or more antimicrobial classes at the same time was defined as
combination treatment.
2.4 | Justification score (JS)
The appropriateness of antimicrobial treatments was assessed by com-
paring them to the recommendations outlined in Table 2. These recom-
mendations were compiled by a panel of clinical specialists and
pharmacologists based on existing national and international consensus
guidelines, which were available in 2016.20,23-25 In all cases for which
sufficient clinical information was recorded, the appropriateness of anti-
microbial prescription was assessed by a previously published justifica-
tion score with modifications (JS-1 to JS-4; Table 3).26 Diversions of
±1 day from the recommended treatment duration and of ±20% of the
recommended dosage were accepted. Every case was recorded only
once and only initial treatments were assessed. In order to determine
the robustness of the score, 60 cases (30 cases from 2016 and 2018
each) were assessed independently by 2 evaluators with an observed
Cohen´s kappa of 0.975 (SE of 0.025; 95% CI of 0.926-1.000).27
2.5 | Statistical analysis
Data were analyzed by the commercial SPSS software (SPSS Inc, Chi-
cago, Illinois). Descriptive statistics were applied for demographic and
clinical data, antimicrobial prescriptions, and JS. Demographic and
clinical data, differences in diagnostic work-up, antibiotic classes, the
use of HPCIAs or combination treatment, duration of treatment, and
JS were compared between dogs presented in 2016 and 2018 by chi
squared test for categorical and Mann-Whitney U test for continuous
variables. The Bonferroni method was applied to correct the signifi-
cance levels for multiple comparisons.
Risk factors for JS-4 (treatment in complete disagreement with
guidelines) were determined by univariate logistic regression analysis.
TABLE 1 Inclusion and exclusion criteria and search terms for the surveyed indications
Indication Included Excluded Search terms






• Diarrhea >3 wk or relapsing
• Diarrhea related to drug administration
or another extradigestive disease
• Diarrhea that started during
hospitalization
• Parvovirosis
Diarrhea, colitis, duodenitis, enteritis, ileitis, gastritis,




• Suspicion or diagnosis of
bacterial cystitis




• Urolithiasis without signs of bacteriuria
Urinary tract infection, dysuria, difficult urination,
stranguria, hematuria, bloody urine, blood in urine,
polyuria, pollakiuria, pyelonephritis, inflammation










• Neoplasia of the respiratory tract
• Lung worms
Respiratory tract infection, respiratory tract disease,
cough, tracheitis, tracheobronchitis, pneumonia,
inflammation of the lungs, bronchitis,
bronchopneumonia, kennel cough, distemper,
influenza, adenovirus, dyspnea, tachypnea
Wound infection • Bite wound
• Abscess
• Anal gland abscess
• Dental abscess
• Abscess because of a foreign body
• Hot-spot
Wound infection, abscess, purulent wound, bite
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Acute diarrhea Antimicrobial treatment NOT indicated
unless suspicion of sepsis based on

















If suspicion of sepsisa and no improvement
with initial treatment after 2 to 3 d,
















Antimicrobial treatment only indicated if
bacteriuria was confirmed by sediment or
culture of urine collected via
cystocentesis.
In previous guidelines, complicated UTI
were defined as infections that occur in
the presence of an anatomic or functional
abnormality or a comorbidity that
predisposes the patient to persistent

































































Aspiration pneumonia or bacterial
bronchopneumonia






























Kennel cough: antimicrobial treatment only
indicated if: poor general condition, rectal










Bite wounds: antimicrobial treatment always
indicated, except damage limited to
epidermis
Abscesses: antimicrobial treatment only
indicated if fever, reduced general
demeanor, very contaminated wound, or
















Abbreviation: UTI, urinary tract infection.




dTreatment as listed for complicated UTI also judged appropriate.
eSevere clinical, laboratory or radiographic signs.
fOnly skin damaged.
gSkin and deeper structures damaged.
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Multivariable logistic regression analysis was attempted but, due to the
low number of dogs in each category for which detailed clinical infor-
mation was available, no relevant associations could be identified.
3 | RESULTS
3.1 | Case characteristics
Case characteristics for each indication examined in the years 2016
and 2018 are shown in Table 4. In total, 2205 dogs were included in
the study, of which 761 were presented to university hospitals and
1444 to private practices. There were no significant differences with
regards to the proportion of cases enrolled for each indication, age,
sex, neuter status, and proportion of pure-bred dogs between 2016
and 2018 (Table 4).
3.2 | Antimicrobial prescriptions overall
The proportion of dogs prescribed antimicrobials decreased signifi-
cantly from 74% (786/1056 dogs) in 2016 to 59% (669/1140 dogs) in
2018 (P < .001). The most commonly prescribed antimicrobial classes
in 2016 and 2018 are shown in Figure 1. The prescription of potenti-
ated aminopenicillins increased significantly from 2016 to 2018,
whereas the prescription of nitroimidazoles decreased significantly.
Overall, the proportion of dogs prescribed HPCIAs did not differ sig-
nificantly between the 2 years.
The distribution of justification scores for the 2 years is shown in
Figure 2. In 2018, there was a significantly higher proportion of cases
in which the appropriateness of treatment could not be assessed
(P < .001). When excluding these cases, there was a significantly
higher proportion of cases in 2018 for which prescribed treatment
was in complete accordance with guidelines (JS-1; 2016: 48%; 2018:
60%; P < .001) and a significantly lower proportion of cases for which
prescribed treatment was in complete disagreement with guidelines
(JS-4; 2016:38%; 2018:24%; P < .001). The proportions of cases
where antimicrobials were prescribed at an incorrect dosage, an incor-
rect treatment duration, or both (JS-2) or where the antimicrobial
class was not in accordance with guidelines (JS-3) were small in both
years and did not change significantly.
3.3 | Antimicrobial prescriptions for acute
diarrhea (AD)
Antimicrobial prescriptions, minimal diagnostic work-up, use of
HPCIAs, combination treatment, duration of treatment in 2016 and
2018 in university hospitals and private practices are shown in
Table 5. The proportion of dogs, which had minimal diagnostic work-
up performed consisting of a CBC, increased significantly from 2016
to 2018 in university hospitals but not in private practices. Both in
university hospitals and in private practices, the proportion of dogs
with AD prescribed antimicrobials decreased significantly from 2016
to 2018.
In university hospitals, the proportion of dogs prescribed
nitroimidazoles in 2018 decreased significantly, while a significantly
higher proportion of dogs was prescribed potentiated aminopenicillins,
fluoroquinolones, or both antimicrobial classes. There was also a signifi-
cantly higher proportion of dogs prescribed combination treatment in
2018 than in 2016.
In private practices, there were no significant changes between
2016 and 2018 regarding the antimicrobial classes prescribed.
The proportions of cases in 2016 and 2018 for which a JS could
be assessed (JS-1-4) and those where missing clinical information pre-
cluded attribution of a JS are shown in Table 5. When excluding cases
where judgment of antimicrobial treatment was impossible the pro-
portion of cases of AD with a JS-1 (complete adherence to guidelines)
increased significantly from 34% to 62% (P < .001) in university hospi-
tals and from 37% to 55% (P = .001) in private practices. At the same
time, the proportion of cases with a JS-4 (complete disagreement with
guidelines) decreased significantly from 54% to 29% (P < .001) in uni-
versity hospitals and from 61% to 43% (P = .001) in private practices.
The proportion of dogs prescribed antimicrobials although not indi-
cated (subpopulation of JS-4) decreased significantly from 52%
(86/164 dogs) in 2016 to 26% (50/195 dogs) in 2018 (P < .001) in
university hospitals and from 61% (101/167 dogs) to 43% (62/145;
P = .002) in private practices. In cases with a JS-3 (antimicrobial class
not in agreement with guidelines), dogs were prescribed a fluoroquin-
olone or metronidazole in 11/17 cases each in 2018, either as mono-
or as combination treatment. In 2016, these had been 1/18 dogs pre-
scribed a fluoroquinolone and 17/18 dogs metronidazole.
The median duration of prescribed antimicrobial treatment was
significantly shorter in 2018 than in 2016 in university hospitals, while
this did not change significantly in private practices (Table 5).
Looking at all cases for which sufficient clinical information was
available, the prescription of combination treatment with 2 or more
TABLE 3 Modified justification score used to judge the
accordance of antimicrobial prescriptions in dogs
Justification
score Criteria
JS-1 Empirical prescription in accordance with
international recommendations, that is, correct
indication, antimicrobial class, dosage and
treatment durationOR correct prescription
according to culture and sensitivity profileOR no
antibiotic indicated, and none prescribed
JS-2 Dosage and/or duration of prescription not in
accordance with guidelines
JS-3 Antimicrobial class not in accordance with guidelines
JS-4 Decision to treat in complete disagreement with
guidelines, that is, antibiotic prescription when not
indicated or no antibiotic prescription although
indicated
Abbreviation: JS, justification score.
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antimicrobial classes was significantly associated with the presence of
lethargy and at least 1 sepsis criterion (body temperature >39.4C,
heart rate >140/min, WBC <4 or >25 × 109/L, banded neutrophils
>1.5 × 109/L; P < .001)19 in both years. Unlike in 2016, the prescrip-
tion of HPCIAs was significantly associated with the presence of sep-
sis criteria (P < .001) in 2018.
In both years, the prescription of antimicrobials was associated
with the presence of hemorrhagic diarrhea (P < .001). However, the
proportion of dogs presented with hemorrhagic diarrhea that were
unnecessarily prescribed antimicrobials decreased significantly from
65% (100/153 dogs) in 2016 to 36% (54/150 dogs) in 2018
(P < .001). Univariate logistic regression analysis revealed that in
2018, dogs with hemorrhagic diarrhea were 1.67 times more likely to
be prescribed antimicrobials in disagreement to guidelines (JS-4) than
dogs with nonhemorrhagic diarrhea (P = .027), while in 2016 they had
been 2.26 times more likely (P < .001).
3.4 | Antimicrobial prescriptions for urinary tract
infections (UTI)
Antimicrobial prescriptions, diagnostic work-up, and justification scores
for UTI in 2016 and 2018 in university hospitals and private practices
are shown in Table 6. The frequency of urine culture or microscopic
sediment analysis performed in dogs with suspected UTI did not
change significantly between 2016 and 2018 regardless of whether
they were presented at university hospitals or private practices. At uni-
versity hospitals, no significant changes in antimicrobial prescribing pat-
terns for UTI could be detected between 2016 and 2018.
At private practices, however, fluoroquinolones were prescribed
significantly less frequently in 2018 while the proportion of
uncastrated males did not change between the 2 years. Unlike in
2016, the prescription of fluoroquinolones was significantly correlated
with a noncastrated male status in 2018 (P < .001).
F IGURE 1 Most commonly
used antimicrobial classes in 2016
and 2018. *P < .001; **P = .001;
other antimicrobial classes were
each used in less than 2% of all
cases and are therefore not
shown
TABLE 4 Characteristics of dogs presented with the indicated diseases in 2016 or 2018
Parameter
Acute diarrhea Urinary tract infections Respiratory tract infections Bite wounds/abscesses
2016 2018 P-value 2016 2018 P-value 2016 2018 P-value 2016 2018 P-value
Total 371 408 .64 245 260 .91 274 306 .55 175 166 .23
Sex .19 .67 .78 .05
Female 173 178 151 160 129 134 91 71
Male 193 223 92 99 143 169 81 86
Unknown 5 7 2 1 2 3 3 9
Age (years) Median (IQRa) 5 (1-9) 5 (2-9) .69 9 (5-11) 9 (4-12) .16 6 (2-11) 7 (2-11) .60 6 (3-9) 7 (3-10) .14
Breed .20 .84 .36 .22
Purebred 305 317 194 200 226 248 133 121
Mixed breed 60 86 47 56 42 55 40 38
Unknown 6 5 4 4 6 3 2 7
aInterquartile range.
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When looking at diagnoses and taking both years together, a signifi-
cantly higher proportion of dogs was diagnosed with a complicated UTI
at university hospitals (109/166 dogs, 66%) than at private practices
(104/339 dogs, 31%; P < .001). There was also a significantly higher pro-
portion of dogs diagnosed with pyelonephritis at university hospitals
(17/166 dogs, 10%) than at private practices (2/339 dogs, 1%; P < .001).
As in 2016, the appropriateness of antimicrobial treatment could
not be determined in over 2 thirds of the cases presented to private
practices in 2018 due to a lack of information in the medical records
or lacking diagnostic work-up.
The proportions of dogs with prescribed treatments in complete
agreement, partial agreement, or disagreement with guidelines did not
significantly change between 2016 and 2018. For cases of uncompli-
cated UTI, the reason for a JS-3 (wrong antimicrobial class) was in the
majority of cases the prescription of potentiated aminopenicillins
instead of the recommended nonpotentiated aminopenicillins (2016:13/
21 cases, 62%; 2018:19/21 cases, 90%).
3.5 | Antimicrobial prescriptions for respiratory
tract infections (RTI)
Antimicrobial prescriptions, diagnostic work-up and justification
scores in 2016 and 2018 in university hospitals and private practices
are listed in Table 7. The proportion of dogs with RTI that were
treated with antimicrobials decreased from 2016 to 2018 both in uni-
versity hospitals and in private practices, but this reduction was only
statistically significant in private practices. The antimicrobial classes
prescribed were not significantly different in 2018 compared to 2016,
with potentiated aminopenicillins and fluoroquinolones being the
most commonly prescribed classes at university hospitals and potenti-
ated and nonpotentiated aminopenicillins as well as tetracyclines the
most commonly prescribed classes at private practices.
A diagnosis of RTI was based only on clinical signs in over 80% of
cases presented to private practices both in 2016 and in 2018. At uni-
versity hospitals, diagnostic work-up was performed more frequently,
and the proportion of cases with at least minimal work-up (thoracic
radiographs and CBC) increased significantly from 2016 to 2018. The
proportion of dogs in which bronchoalveolar lavage (BAL) was per-
formed remained generally low in 2018.
Looking at cases from 2016 and 2018 together, the most com-
mon diagnosis in university hospitals was aspiration pneumonia
(93/233 dogs, 40%), which was rarely diagnosed in private practices
(6/347 dogs, 2%; P < .001). Bacterial pneumonia was only diagnosed
in 2 dogs (1%) at university hospitals and none in private practices.
Veterinarians suspected Canine Infectious Respiratory Disease Com-
plex in 29 dogs (12%) at university hospitals and in 20 dogs (6%) at
private practices (P = .005, not significant after Bonferroni correction).
F IGURE 2 Proportions of justification scores in 2016 and 2018
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The proportion of cases without a confirmed diagnosis was signifi-
cantly lower in university hospitals (73/233 dogs, 31%) than in private
practices (312/347 dogs, 90%; P < .001).
In university hospitals as well as in private practices, the propor-
tion of cases where accordance to guidelines could not be judged was
significantly higher in 2018 (Table 7). When excluding these cases, the
proportion of JS-1 (complete adherence to guidelines) increased
mildly but not significantly from 2016 to 2018 in university hospitals
(2016:66%; 2018:72%; P = .34), and significantly in private practices
(2016:52%; 2018:75%; P = .001). The proportion of cases with JS-4
(complete disagreement with guidelines) decreased significantly both
in university hospitals (2016:18%; 2018:8%; P = .022) and private
practices (2016:37%; 2018:15%; P < .001). For all cases in which judg-
ment was possible, the proportion of dogs prescribed antimicrobials
although not indicated decreased significantly from 18% (19/103
dogs) in 2016 to 0% (0/104 dogs) in 2018 (P < .001) in university hos-
pitals and from 35% (43/123 dogs) to 13% (13/102 dogs; P < .001) in
private practices.
3.6 | Antimicrobial prescriptions for abscesses and
bite wounds (WI)
Antimicrobial prescriptions and justification scores for abscesses and
bite wounds in private practices in 2016 and 2018 are shown in
Table 8. No significant changes between the 2 years were found
regarding antimicrobial prescriptions. As in 2016, the majority of dogs
were prescribed antimicrobials in 2018, the most commonly used clas-
ses being potentiated and nonpotentiated aminopenicillins and first
generation cephalosporins.
Of all dogs presented for abscesses and prescribed antimicrobials,
the proportion of dogs not showing any indications for antimicrobial
use listed in the guidelines (fever, lethargy, severely contaminated
wound, or proximity to fragile tissues) decreased mildly but not signifi-
cantly from 2016 to 2018 (2016:36%; 2018:26%; P = .30).
The proportion of dogs receiving local wound treatment, which is
considered an important part of the treatment of abscesses and bite
wounds28,29 increased between 2016 and 2018, while the proportion
of dogs in which drains were placed did not increase (Table 8).
The proportion of cases where no JS could be applied was signifi-
cantly higher in 2018 compared to 2016. When excluding these cases,
there were no significant differences in the proportion of cases with
JS-1 (2016: 64%; 2018: 60%; P = .52) and JS-4 (complete disagree-
ment with guidelines; 2016: 17%; 2018: 15%; P = .71).
4 | DISCUSSION
ASPs are efficient measures to foster prudent antimicrobial use in
human and veterinary medicine.3-13 This study evaluates the effects
TABLE 5 Antimicrobial prescriptions and justification scores for acute diarrhea in 2016 and 2018 in university hospitals and private practices
University hospitals Private practices
2016 2018 P-value 2016 2018 P-value
Total number of cases 165 197 206 211


























































At least 1 HPCIA prescribed 3 (3%) 18 (23%) <.001 18 (14%) 6 (7%) .08
Combination treatment 11 (10%) 24 (30%) <.001 6 (5%) 6 (7%) .54
Duration (d) Median (IQR) 9 (7-11.5) 6 (5-10) .001 7 (5-9) 6 (5-9) .76





































Note: Bonferroni corrected P-value for significance ≤.003.
Abbreviations: HPCIA, highest priority critically important antimicrobial; JS, justification score.
aCBC.
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of an online ASP tool in small animal medicine and applies a detailed
justification score to accurately evaluate changes of antimicrobial
prescriptions.
The ASP of this study (AntibioticScout.ch) is an online tool that
allows veterinarians to quickly retrieve recommendations for prudent
antimicrobial use for specific indications online. The tool was introduced
at the end of December 2016 along with a bundle of educational mea-
sures including conference talks, workshops, and press releases promot-
ing an attitude of prudent antimicrobial use as part of the National
Strategy on Antimicrobial Resistance (StAR). At the time of writing,
AnitibioticScout.ch is accessed more than 400 times per day.
A retrospective analysis of 2205 case files demonstrated that the
proportion of dogs treated with antimicrobials significantly decreased
between 2016 and 2018. At the same time, the proportion of thera-
pies in complete accordance with guidelines (JS-1) increased and the
proportion of treatments in complete disagreement (JS-4) decreased.
These findings suggest that the introduction of AntibioticScout.ch, in
the context of other implemented educational measures, led to a
more prudent use of antimicrobials in the participating practices and
hospitals.
The most common deviations from prudent use in both years
were prescription of antimicrobials where none were needed for AD,
unconfirmed UTI, and wounds or abscesses that could have been
managed with local wound treatment only.
Substantial changes in prescribing were seen in dogs presented
for AD (Table 5). For this subgroup, the prescription of antimicrobials
decreased significantly, and a significantly higher proportion of dogs
was prescribed in accordance with guidelines, which recommend the
use of antimicrobials only in cases with suspected sepsis.24,25 Unlike
in 2016, the prescription of HPCIAs was significantly correlated
with the presence of sepsis criteria in 2018, which implies a more pru-
dent use of HPCIAs. Nevertheless, over 3/4 of the cases where
fluoroquinolones were prescribed in 2018 were judged with JS-3
(wrong antimicrobial class) or JS-4 (complete disagreement with
guidelines), suggesting that a large proportion of the prescribed
fluoroquinolones was still unnecessary. This should be monitored
closely in the future to ensure the sustainable use of these important
drugs.
As in dogs with nonhemorrhagic diarrhea, the use of antimicro-
bials in dogs with hemorrhagic diarrhea without signs of sepsis has
been considered unnecessary for many years now, as it does not
change the outcome.18,30,31 In 2018, the proportion of dogs with
hemorrhagic diarrhea that were prescribed antimicrobials although
not indicated decreased significantly. This finding suggests that a
TABLE 6 Antimicrobial prescriptions, diagnostic work-up and justification scores for urinary tract infections in 2016 and 2018 in university
hospitals and private practices
University hospitals Private practices
2016 2018 P-value 2016 2018 P-value
Total number of cases 70 96 175 164








































































At least 1 HPCIA prescribed 12 (18%) 25 (28%) .12 46 (31%) 18 (14%) .001
Combination treatment 5 (7%) 3 (3%) .27 0 (0%) 4 (3%) .03
Duration (d) Median (IQR) 21 (10-27.5) 15 (10-28) .43 10 (8-14) 10 (7-14) .40
Culture performed 67 (96%) 91 (95%) .78 43 (25%) 31 (19%) .21
Microscopic sediment analysis performed 59 (84%) 77 (80%) .50 73 (42%) 75 (46%) .77





































Note: Bonferroni corrected P-value for significance ≤.002.
Abbreviations: HPCIA, highest priority critically important antimicrobial; JS, justification score.
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growing proportion of veterinarians in Switzerland is aware of the rec-
ommendations for treatment of diarrhea and prescribes antimicrobials
accordingly. Since the use of antimicrobials in dogs with hemorrhagic
diarrhea has long been endorsed irrespective of signs of sepsis,32 it is
comprehensible that it will take more time and continuous education
until the majority of veterinarians adapt their treatment habits for this
condition.
For the treatment of proven or suspected UTI, no significant
changes were found regarding antimicrobial classes prescribed in uni-
versity hospitals (Table 6). In private practices, the proportion of
dogs prescribed aminopenicillins (potentiated and nonpotentiated)
increased significantly from 2016 to 2018, while that prescribed
fluoroquinolones decreased significantly. Although fluoroquinolones
are not first-line drugs for UTI, their prescription has been rec-
ommended for the treatment of uncastrated male dogs with UTI until
recently.33 This was due to the belief that the prostate is usually
infected in uncastrated male dogs with UTI, thereby requiring treat-
ment with an antibiotic with good penetration into the prostate.34-36
In the new guidelines by the International Society for Companion
Animal Infectious Diseases (ISCAID) the use of fluoroquinolones in
uncastrated males is only recommended if there is evidence of pros-
tatic involvement.21 The proportion of uncastrated males presented
to private practices did not differ significantly between 2016 and
2018 and the prescription of fluoroquinolones was associated with an
uncastrated male status only in 2018. These findings show that
fluoroquinolones were mostly prescribed to uncastrated male dogs in
2018, which, together with the significantly lower proportion of dogs
treated with fluoroquinolones, suggests a more prudent use of
fluoroquinolones for UTI in private practices in 2018.
However, this survey could not show a significant increase in the
proportion of UTI cases in accordance with guidelines, which could be
due at least partly to the high proportion of instances where no judg-
ment was possible. The fact that in more than two thirds of cases in
private practices a judgment of the appropriateness of antimicrobial
treatment was not possible highlights that adequate diagnostic steps
are still undertaken only in a minority of dogs presented with signs of
UTI. This finding is consistent with results of previous reports.37-39 In
a study from Denmark, even when looking only at the subgroup of
guideline-users (a group of veterinarians expected to be interested in
prudent antimicrobial use), only 39% stated to frequently perform
TABLE 7 Antimicrobial prescriptions, diagnostic work-up and justification scores for respiratory tract infections in 2016 and 2018 in
university hospitals and private practices
University hospitals Private practices
2016 2018 P-value 2016 2018 P-value
Total number of cases 108 125 166 181








































































At least 1 HPCIA prescribed 25 (31%) 27 (33%) .78 7 (8%) 5 (9%) .82
Combination treatment 18 (22%) 23 (28%) .39 4 (5%) 1 (2%) .38
Duration (d) Median (IQR) 14 (10-21) 15 (8-28) .32 9 (6.5-11) 8 (7-10) .44
Clinical exam only 6 (6%) 3 (2%) .21 145 (87%) 155 (86%) .64
At least minimal work-upa performed 75 (69%) 101 (81%) .04 1 (.6%) 3 (2%) .36





































Note: Bonferroni corrected p-value for significance ≤.002.
Abbreviations: BAL, bronchoalveolar lavage; HPCIA, highest priority critically important antimicrobial; JS, justification score.
aThoracic radiographs and CBC.
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culture and sensitivity testing before treating a UTI.11 The same study
found the main barriers for veterinarians to perform culture and sensi-
tivity testing to be good experiences with empiric treatments and
owners' financial concerns.
Another reason for the lack of complete adherence to guidelines
is the still frequent use of potentiated aminopenicillins in cases of
uncomplicated/sporadic UTI instead of the recommended non-
potentiated aminopenicillins.
Both in university hospitals and private practices, the duration of
antimicrobial treatment for UTI did not change significantly (Table 6).
At university hospitals, long treatment durations were common. This
can be explained by the significantly higher proportions of dogs with
complicated UTI and pyelonephritis treated at university hospitals
compared to private practices, as earlier guidelines suggested treating
complicated UTI with antimicrobials for 4 weeks and pyelonephritis
for 4 to 6 weeks.20 However, the new ISCAID guidelines recommend
a much shorter treatment of 3-14 days, depending on the specific sit-
uation.21 For sporadic UTI, the recommended treatment duration has
been decreased from 7-14 days to 3-5 days.20,21 The recommenda-
tions on AntibioticScout.ch have been revised accordingly.
For dogs presented with signs of RTI, there was a higher propor-
tion of prescriptions in complete accordance with guidelines and a
lower proportion of treatments in complete disagreement with guide-
lines in 2018. In private practices, the prescription of antimicrobials
decreased significantly, while it decreased only mildly in university
hospitals (Table 7). A possible explanation for this finding is the signif-
icantly higher proportion of dogs with aspiration pneumonia
presented at university hospitals, a condition for which the use of
antimicrobials is commonly deemed necessary. In private practices, a
high proportion of dogs is presented because of acute coughing with-
out signs of systemic disease—cases in which antimicrobials are not
indicated.23
The differences in the cases presented also likely explain the
much more common use of further diagnostics at university hospitals
(Table 7). The proportion of dogs in which diagnosis was based on
clinical signs and clinical examination findings alone was high in pri-
vate practices in both years. However, this is understandable consid-
ering the high proportion of dogs with mild and uncomplicated
coughing presented to private practices. In these cases, further diag-
nostic tests are often not recommended in the absence of signs of
pneumonia.23
For dogs presented with abscesses and bite wounds, there were
no significant differences between 2016 and 2018 regarding the pro-
portion of dogs prescribed antimicrobials and the adherence to guide-
lines (Table 8). While for bite wounds, antimicrobial treatment is
recommended for the majority of cases (unless only the epidermis is
damaged), it is rarely indicated to treat abscesses unless there are
signs of a generalized infection (lethargy, fever), severely contami-
nated lesions, or lesions close to fragile tissues.33,40 The proportion of
dogs presented for abscesses and treated with antimicrobials in the
absence of a clinical sign listed in the guidelines decreased from 36%
to 26%. Although this finding was not statistically significant, it might
still indicate a slightly more prudent antimicrobial use for treatment of
abscesses in 2018. A similar result was found for bite wound
TABLE 8 Antimicrobial prescriptions and justifications scores for abscesses and bite wounds in 2016 and 2018 in private practices
2016 2018 P-value
Total number of cases 175 166






























At least 1 HPCIA prescribed 7 (5%) 5 (3%) .64
Combination therapy 3 (2%) 6 (4%) .26
Duration (d) Median (IQR) 7 (6-10) 8 (7-11) .13
Local wound treatment 113 (65%) 124 (75%) .04






















Note: Bonferroni corrected P-value for significance ≤.003.
Abbreviations: HPCIA, highest priority critically important antimicrobial; JS, justification score.
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abscesses in cats in Switzerland, where 96% were treated with antimi-
crobials while only 30% showed at least 1 clinical sign that would jus-
tify antimicrobial treatment.16
As in 2016, potentiated aminopenicillins were used to treat the
majority of abscesses and bite wounds in 2018, which is in accor-
dance with current recommendations. In contrast, in 2016, 1 quarter
of cats in Switzerland presented for abscesses were treated with a
third generation cephalosporin, a subclass classified as HPCIA, which
should be reserved for infections with bacteria that are resistant to
first line antimicrobials.16 A possible explanation for this difference is
that it is easier to administer oral medication in dogs than cats, and
the only injectable antimicrobial with a long duration of action regis-
tered for cats in Switzerland is cefovecin.
Local treatment is a very important part of the treatment of
wounds, and can be sufficient without the addition of systemic anti-
microbial treatment, especially for abscesses.28,29 The finding that the
proportion of dogs receiving local wound treatment increased sug-
gests that a growing proportion of veterinarians in Switzerland is
aware of its importance. However, in most cases, antimicrobials are
still added as a preventive measure.
Although this study found a significantly more prudent prescrip-
tion of antimicrobials in 2018 compared to 2016, there are still some
aspects that require improvement. Previous reports on the impact of
ASPs revealed similar findings.11,12 Several studies have investigated
the barriers of prudent antimicrobial use in veterinary medicine.
According to their results, the main barriers seem to be old prescribing
habits, unavailability of recommended drugs on the national market,
client expectations, the fact that diagnostic tests are cost- and time-
consuming, fear of negative consequences for animals or for the vet-
erinarians themselves due to nonprescription of antimicrobials, and
the convenience of administration of some drugs.11,41,42 Furthermore,
veterinary medicine faces the problem of discordant opinions con-
cerning the treatment of some conditions, as well as various
knowledge-gaps (ie, adequate treatment duration for UTI).21,42 On the
other hand, factors leading to a more prudent use of antimicrobials
were found to be awareness of antimicrobial resistance, prevention of
infections, professional learning, and regulatory measures by the gov-
ernment or other institutions.41
Further efforts should be made addressing and counteracting the
identified barriers while fostering the drivers of prudent antimicrobial
use. Since October 2019, veterinarians in Switzerland are obliged to
report signalment, indication, product, dosage, and duration of treat-
ment for every antimicrobial prescription via direct data transfer to
the competent authority (Information System on Antibiotics in Veteri-
nary Medicine; IS-ABV). The goals of this new requirement are to
more closely monitor antimicrobial prescriptions in small animals, to
evaluate the effects of established actions, and to compare antimicro-
bial use on a regional, national, and international level.43 In the future,
veterinarians will receive a feedback regarding their reported antimi-
crobial prescriptions in comparison to national benchmarks. Further
possible actions could include the distribution of nonprescription leaf-
lets, handed out to owners of animals that do not require antimicro-
bial treatments.44
The limitations of this study are partly due to its retrospective
design. Insufficient documentation of clinical and laboratory findings
precluded judgment of antimicrobial prescriptions in a substantial
proportion of cases. Moreover, as private practices participated on a
voluntary basis, a certain selection bias cannot be excluded. The
practices taking part in the study might be more aware of the impor-
tance of prudent antimicrobial use and might therefore not accu-
rately represent the situation in all practices across Switzerland.
Furthermore, data were collected and evaluated manually, leaving
some room for interpretation and confirmation bias. To allow
comparison between 2016 and 2018, criteria used to judge the
appropriateness of prescriptions were based on guidelines that were
available in 2016. For some conditions, recommendations regarding
antimicrobial treatment have changed since then. Thus, some of the
included cases might have been judged differently according to
newer guidelines.
The justification score was developed for this study based on
published literature.26 For reasons of simplicity, the categories “inap-
propriate dosage” and “inappropriate duration of treatment” were
grouped into 1 category (JS-2). In future studies, separate scoring of
these 2 categories should be considered in order to refine the
assessment.
The exact impact of AntibioticScout.ch is hard to evaluate, as it
was implemented in the context of other national measures aiming for
a more prudent use of antimicrobials. Moreover, the worldwide
awareness of antimicrobial resistance and the need to preserve the
effectiveness of antimicrobials is rising. It is likely that this fact also
had an influence on the changes in prescribing patterns found in this
study. However, a user-friendly decision support tool like
AntibioticScout.ch providing specific recommendations likely supports
veterinary practitioners in correctly adopting prudent use principles.
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